In developing countries, treating children with pneumonia at home is as safe and effective as hospital care, a new study finds. Worldwide, pneumonia kills 2 million children under the age of 5 each year. However, antibiotics given at home could significantly reduce deaths, the researchers report. ‘Severe in pneumonia in children can be safely and successfully treated at home versus the current standard of care, which is hospitalization,’ said lead researcher Dr. Donald Thea, a professor of international health at Boston University School of Public Health. ‘Pneumonia is the biggest killer of children in the world.’ Thea’s team studied 2,037 children aged 3 to 59 months at seven sites in Pakistan. About half the children received amoxicillin syrup and were sent home, and the others received intravenous antibiotics in the hospital, according to the report in the Jan. 5 issue ofThe Lancet. Among the children treated in the hospital, 87 didn’t respond to the antibiotic, compared with 77 who were treated at home. Five children died within two weeks; one was treated at home and four were treated in the hospital. Based on these findings, Thea hopes the World Health Organization (WHO) will change its […]
Saturday, January 5th, 2008
Treating Childhood Pneumonia at Home Could Save Lives in Developing Countries
Author: STEVEN REINBERG
Source: Washington Post
Publication Date: Friday, January 4, 2008; 12:00 AM
Link: Treating Childhood Pneumonia at Home Could Save Lives in Developing Countries
Source: Washington Post
Publication Date: Friday, January 4, 2008; 12:00 AM
Link: Treating Childhood Pneumonia at Home Could Save Lives in Developing Countries
Stephan: SOURCES: Donald Thea, M.D., professor, international health, Boston University School of Public Health; William Schaffner, M.D., vice president, National Foundation for Infectious Diseases, and chairman, Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville; Jan. 5, 2008,The Lancet.
For more information on pneumonia, visit the U.S. National Institute of Allergy and Infectious Diseases.